PMID

Data

Article Title

Organization

Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease.

Cellzome

A one-pot synthesis and biological activity of ageladine A and analogues.

Macquarie University

A quantitative analysis of kinase inhibitor selectivity.

Ambit Biosciences

Comprehensive analysis of kinase inhibitor selectivity.

Ambit Biosciences

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).

Ambit Biosciences

Selectively nonselective kinase inhibition: striking the right balance.

Schering-Plough

Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.

Glaxosmithkline

Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain.

Bristol-Myers Squibb

Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 Inhibitors.

Bristol Myers Squibb

Kinase Inhibitors as Underexplored Antiviral Agents.

Centro De Investigaciones Biol�Gicas Margarita Salas (Csic)

Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.

Csir-Indian Institute Of Integrative Medicine

A small molecule-kinase interaction map for clinical kinase inhibitors.

Ambit Biosciences

Discovery of (

Bristol-Myers Squibb

Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration.

University Of North Carolina At Chapel Hill

Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain.

Bristol Myers Squibb

Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.

Biogen

SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).

Johann Wolfgang Goethe University

Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor.

Cellzome

SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K.

University Of North Carolina At Chapel Hill (Unc-Ch)

Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application.

Takeda Pharmaceutical

Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.

Ku Leuven

Inhibitors of Adaptor-Associated Kinase 1 (AAK1) May Treat Neuropathic Pain, Schizophrenia, Parkinson's Disease, and Other Disorders.

Therachem Research Medilab (India)